{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:17:20Z","timestamp":1787498240544,"version":"build-2736575974"},"reference-count":76,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This practice guideline follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and serves as a guideline for use in clinical practice.<\/jats:p>","DOI":"10.1515\/jpm-2022-0066","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T23:42:50Z","timestamp":1647214970000},"page":"375-385","source":"Crossref","is-referenced-by-count":30,"title":["The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation"],"prefix":"10.1515","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-5839","authenticated-orcid":false,"given":"Themistoklis","family":"Dagklis","sequence":"first","affiliation":[{"name":"Third Department of Obstetrics and Gynaecology, Faculty of Health Sciences,School of Medicine , Aristotle University of Thessaloniki , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-6840","authenticated-orcid":false,"given":"Cihat","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Perinatal Medicine, Obstetrics and Gynecology , Perinatal Medicine Foundation and Istanbul University-Cerrahpasa , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-7871","authenticated-orcid":false,"given":"Ioannis","family":"Tsakiridis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, School of Medicine Faculty of Health Sciences , Aristotle University of Thessaloniki Third , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9456-4100","authenticated-orcid":false,"given":"Cecilia","family":"Villala\u00edn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , University Hospital 12 de Octubre, Complutense University of Madrid, Fetal Medicine Unit , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-5105","authenticated-orcid":false,"family":"Karel Allegaert","sequence":"additional","affiliation":[{"name":"KU Leuven , Leuven , Belgium"},{"name":"Hospital Pharmacy, Erasmus MC , Rotterdam , The Netherlands"},{"name":"Department of Development and Regeneration, and Department of Pharmaceutical and Pharmacological Sciences , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9230-6266","authenticated-orcid":false,"given":"Sven","family":"Wellmann","sequence":"additional","affiliation":[{"name":"Department of Neonatology , University Children\u2019s Hospital Regensburg (KUNO), Hospital St. Hedwig of the Order of St. John, University of Regensburg , Regensburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-8877","authenticated-orcid":false,"given":"Satoshi","family":"Kusuda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Kyorin University , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-3628","authenticated-orcid":false,"given":"Bernat","family":"Serra","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproduction , Hospital Universitari Dexeus , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9543-7392","authenticated-orcid":false,"given":"Manuel","family":"Sanchez Luna","sequence":"additional","affiliation":[{"name":"Neonatology Division and NICU , Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n\u201d Complutense University of Madrid , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-8419","authenticated-orcid":false,"given":"Erasmo","family":"Huertas","sequence":"additional","affiliation":[{"name":"Department of Obstetric and Gynecology , San Marcos National University , Lima , Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-5602","authenticated-orcid":false,"given":"Nicola","family":"Volpe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Azienda Ospedaliero-Universitaria di Parma Fetal Medicine Unit , Parma , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2548-3208","authenticated-orcid":false,"given":"Rodrigo","family":"Ayala","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Centro Medico ABC Santa Fe , Mexico City , Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-5996","authenticated-orcid":false,"given":"Nelly","family":"Jekova","sequence":"additional","affiliation":[{"name":"Department of Neonatology , University Hospital of Obstetrics and Gynecology \u201cMaichin dom\u201d, Medical University , Sofia , Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0308-0232","authenticated-orcid":false,"given":"Amos","family":"Grunebaum","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Barbara and Donald Zucker School of Medicine at Hofstra\/Northwell and Lenox Hill Hospital , New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Stanojevic","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Neonatal Unit , Medical School University of Zagreb, Clinical Hospital \u201eSveti Duh\u201c , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"2023040100043917217_j_jpm-2022-0066_ref_001","unstructured":"World Health Organization (WHO 2016). ICD-10: international statistical classification of diseases and related health problems: tenth revision. 5th ed. https:\/\/icd.who.int\/browse10\/Content\/statichtml\/ICD10Volume2_en_2016.pdf [Accessed 30 Dec 2021]."},{"key":"2023040100043917217_j_jpm-2022-0066_ref_002","doi-asserted-by":"crossref","unstructured":"Romero, R, Dey, SK, Fisher, SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760\u20135.https:\/\/doi.org\/10.1126\/science.1251816.","DOI":"10.1126\/science.1251816"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_003","doi-asserted-by":"crossref","unstructured":"Stoll, BJ, Hansen, NI, Bell, EF, Walsh, MC, Carlo, WA, Shankaran, S, et al.. Trends in care practices, morbidity, and mortality of extremely preterm neonates 1993\u20132012. JAMA 2015;314:1039\u201351. https:\/\/doi.org\/10.1001\/jama.2015.10244.","DOI":"10.1001\/jama.2015.10244"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_004","doi-asserted-by":"crossref","unstructured":"Dagklis, T, Tsakiridis, I, Papazisis, G, Athanasiadis, A. Efficacy and safety of corticosteroids\u2019 administration for pulmonary immaturity in anticipated preterm delivery. Curr Pharm Des 2021;27:3754\u201361. https:\/\/doi.org\/10.2174\/1381612826666201207102910.","DOI":"10.2174\/1381612826666201207102910"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_005","doi-asserted-by":"crossref","unstructured":"Liggins, GC, Howie, RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515\u201325. https:\/\/doi.org\/10.1542\/peds.50.4.515.","DOI":"10.1542\/peds.50.4.515"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_006","doi-asserted-by":"crossref","unstructured":"Adams, TM, Kinzler, WL, Chavez, MR, Vintzileos, AM. The timing of administration of antenatal corticosteroids in women with indicated preterm birth. Am J Obstet Gynecol 2015;212:645.e1\u20134. https:\/\/doi.org\/10.1016\/j.ajog.2014.11.021.","DOI":"10.1016\/j.ajog.2014.11.021"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_007","doi-asserted-by":"crossref","unstructured":"van der Laan, S, Meijer, OC. Pharmacology of glucocorticoids: beyond receptors. Eur J Pharmacol 2008;585:483\u201391. https:\/\/doi.org\/10.1016\/j.ejphar.2008.01.060.","DOI":"10.1016\/j.ejphar.2008.01.060"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_008","doi-asserted-by":"crossref","unstructured":"Hillman, NH, Kallapur, SG, Jobe, AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol 2012;39:769\u201383. https:\/\/doi.org\/10.1016\/j.clp.2012.09.009.","DOI":"10.1016\/j.clp.2012.09.009"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_009","doi-asserted-by":"crossref","unstructured":"Rubarth, LB, Quinn, J. Respiratory development and respiratory distress syndrome. Neonatal Netw 2015;34:231\u20138. https:\/\/doi.org\/10.1891\/0730-0832.34.4.231.","DOI":"10.1891\/0730-0832.34.4.231"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_010","doi-asserted-by":"crossref","unstructured":"Jobe, AH. The Amazing premature lung. Am J Perinatol 2019;36:S1\u20133. https:\/\/doi.org\/10.1055\/s-0039-1691768.","DOI":"10.1055\/s-0039-1691768"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_011","doi-asserted-by":"crossref","unstructured":"Whitsett, JA, Matsuzaki, Y. Transcriptional regulation of perinatal lung maturation. Pediatr Clin N Am 2006;53:873\u201387. https:\/\/doi.org\/10.1016\/j.pcl.2006.08.009.","DOI":"10.1016\/j.pcl.2006.08.009"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_012","doi-asserted-by":"crossref","unstructured":"Ballard, PL, Ballard, RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254\u201362.https:\/\/doi.org\/10.1016\/0002-9378(95)90210-4.","DOI":"10.1016\/0002-9378(95)90210-4"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_013","doi-asserted-by":"crossref","unstructured":"Hogan, M, Kuliszewski, M, Lee, W, Post, M. Regulation of phosphatidylcholine synthesis in maturing type II cells: increased mRNA stability of CTP:phosphocholine cytidylyltransferase. Biochem J 1996;314(Pt 3):799\u2013803. https:\/\/doi.org\/10.1042\/bj3140799.","DOI":"10.1042\/bj3140799"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_014","doi-asserted-by":"crossref","unstructured":"McEvoy, C, Schilling, D, Peters, D, Tillotson, C, Spitale, P, Wallen, L, et al.. Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial. Am J Obstet Gynecol 2010;202:544.e1\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2010.01.038.","DOI":"10.1016\/j.ajog.2010.01.038"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_015","doi-asserted-by":"crossref","unstructured":"Seidner, S, Pettenazzo, A, Ikegami, M, Jobe, A. Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol 1988;64:2366\u201371. https:\/\/doi.org\/10.1152\/jappl.1988.64.6.2366.","DOI":"10.1152\/jappl.1988.64.6.2366"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_016","doi-asserted-by":"crossref","unstructured":"Roberts, D, Dalziel, S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006:CD004454.https:\/\/doi.org\/10.1002\/14651858.CD004454.pub2.","DOI":"10.1002\/14651858.CD004454.pub2"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_017","doi-asserted-by":"crossref","unstructured":"Elimian, A, Figueroa, R, Spitzer, AR, Ogburn, PL, Wiencek, V, Quirk, JG. Antenatal corticosteroids: are incomplete courses beneficial? Obstet Gynecol 2003;102:352\u20135. https:\/\/doi.org\/10.1097\/00006250-200308000-00025.","DOI":"10.1097\/00006250-200308000-00025"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_018","doi-asserted-by":"crossref","unstructured":"Vermillion, ST, Soper, DE, Newman, RB. Is betamethasone effective longer than 7\u00a0days after treatment? Obstet Gynecol 2001;97:491\u20133. https:\/\/doi.org\/10.1097\/00006250-200104000-00002.","DOI":"10.1097\/00006250-200104000-00002"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_019","doi-asserted-by":"crossref","unstructured":"Peaceman, AM, Bajaj, K, Kumar, P, Grobman, WA. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol 2005;193:1165\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2005.06.050.","DOI":"10.1016\/j.ajog.2005.06.050"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_020","doi-asserted-by":"crossref","unstructured":"Bonanno, C, Wapner, RJ. Antenatal corticosteroids in the management of preterm birth: are we back where we started? Obstet Gynecol Clin N Am. 2012;39:47\u201363. https:\/\/doi.org\/10.1016\/j.ogc.2011.12.006.","DOI":"10.1016\/j.ogc.2011.12.006"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_021","doi-asserted-by":"crossref","unstructured":"Gates, S, Brocklehurst, P. Decline in effectiveness of antenatal corticosteroids with time to birth: real or artefact? BMJ 2007;335:77\u20139. https:\/\/doi.org\/10.1136\/bmj.39225.677708.80.","DOI":"10.1136\/bmj.39225.677708.80"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_022","doi-asserted-by":"crossref","unstructured":"Savitz, DA, Terry, JWJr., Dole, N, Thorp, JMJr., Siega-Riz, AM, Herring, AH. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol. 2002;187:1660\u20136. https:\/\/doi.org\/10.1067\/mob.2002.127601.","DOI":"10.1067\/mob.2002.127601"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_023","doi-asserted-by":"crossref","unstructured":"Loughna, P, Chitty, L, Evans, T, Chudleigh, T. Fetal size and dating: charts recommended for clinical obstetric practice. Ultrasound 2009;17:161\u20137.https:\/\/doi.org\/10.1179\/174313409x448543.","DOI":"10.1179\/174313409X448543"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_024","doi-asserted-by":"crossref","unstructured":"Berghella, V, Saccone, G. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2019;7:CD006843.https:\/\/doi.org\/10.1002\/14651858.CD006843.pub3.","DOI":"10.1002\/14651858.CD006843.pub3"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_025","doi-asserted-by":"crossref","unstructured":"Berghella, V, Saccone, G. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev 2019;9:CD007235.https:\/\/doi.org\/10.1002\/14651858.CD007235.pub4.","DOI":"10.1002\/14651858.CD007235.pub4"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_026","doi-asserted-by":"crossref","unstructured":"Tsoi, E, Fuchs, IB, Rane, S, Geerts, L, Nicolaides, KH. Sonographic measurement of cervical length in threatened preterm labor in singleton pregnancies with intact membranes. Ultrasound Obstet Gynecol 2005;25:353\u20136. https:\/\/doi.org\/10.1002\/uog.1809.","DOI":"10.1002\/uog.1809"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_027","doi-asserted-by":"crossref","unstructured":"DeFranco, EA, Lewis, DF, Odibo, AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013;208:233.e1\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2012.12.015.","DOI":"10.1016\/j.ajog.2012.12.015"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_028","doi-asserted-by":"crossref","unstructured":"Park, CK, Isayama, T, McDonald, SD. Antenatal corticosteroid therapy before 24 Weeks of gestation: a systematic review and meta-analysis. Obstet Gynecol 2016;127:715\u201325. https:\/\/doi.org\/10.1097\/aog.0000000000001355.","DOI":"10.1097\/AOG.0000000000001355"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_029","doi-asserted-by":"crossref","unstructured":"Carlo, WA, McDonald, SA, Fanaroff, AA, Vohr, BR, Stoll, BJ, Ehrenkranz, RA, et al.. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25\u00a0weeks\u2019 gestation. JAMA 2011;306:2348\u201358.https:\/\/doi.org\/10.1001\/jama.2011.1752.","DOI":"10.1001\/jama.2011.1752"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_030","doi-asserted-by":"crossref","unstructured":"Ehret, DEY, Edwards, EM, Greenberg, LT, Bernstein, IM, Buzas, JS, Soll, RF, et al.. Association of antenatal steroid exposure with survival among infants receiving postnatal life support at 22 to 25 Weeks\u2019 gestation. JAMA Netw Open 2018;1:e183235. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3235.","DOI":"10.1001\/jamanetworkopen.2018.3235"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_031","doi-asserted-by":"crossref","unstructured":"Backes, CH, Rivera, BK, Pavlek, L, Beer, LJ, Ball, MK, Zettler, ET, et al.. Proactive neonatal treatment at 22\u00a0weeks of gestation: a systematic review and meta-analysis. Am J Obstet Gynecol 2021;224:158\u201374. https:\/\/doi.org\/10.1016\/j.ajog.2020.07.051.","DOI":"10.1016\/j.ajog.2020.07.051"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_032","doi-asserted-by":"crossref","unstructured":"McGoldrick, E, Stewart, F, Parker, R, Dalziel, SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2020;12:CD004454. https:\/\/doi.org\/10.1002\/14651858.CD004454.pub4.","DOI":"10.1002\/14651858.CD004454.pub4"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_033","doi-asserted-by":"crossref","unstructured":"Althabe, F, Belizan, JM, McClure, EM, Hemingway-Foday, J, Berrueta, M, Mazzoni, A, et al.. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 2015;385:629\u201339. https:\/\/doi.org\/10.1016\/s0140-6736(14)61651-2.","DOI":"10.1016\/S0140-6736(14)61651-2"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_034","doi-asserted-by":"crossref","unstructured":"Collaborators, WAT, Oladapo, OT, Vogel, JP, Piaggio, G, Nguyen, MH, Althabe, F, et al.. Antenatal dexamethasone for early preterm birth in low-Resource countries. N Engl J Med 2020;383:2514\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2022398.","DOI":"10.1056\/NEJMoa2022398"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_035","doi-asserted-by":"crossref","unstructured":"Deshmukh, M, Patole, S. Antenatal corticosteroids for impending late preterm (34-36+6\u00a0weeks) deliveries-A systematic review and meta-analysis of RCTs. PLoS One 2021;16:e0248774. https:\/\/doi.org\/10.1371\/journal.pone.0248774.","DOI":"10.1371\/journal.pone.0248774"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_036","doi-asserted-by":"crossref","unstructured":"Gyamfi-Bannerman, C, Thom, EA, Blackwell, SC, Tita, AT, Reddy, UM, Saade, GR, et al.. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016;374:1311\u201320. https:\/\/doi.org\/10.1056\/nejmoa1516783.","DOI":"10.1056\/NEJMoa1516783"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_037","doi-asserted-by":"crossref","unstructured":"Kamath-Rayne, BD, Rozance, PJ, Goldenberg, RL, Jobe, AH. Antenatal corticosteroids beyond 34\u00a0weeks gestation: what do we do now? Am J Obstet Gynecol 2016;215:423\u201330. https:\/\/doi.org\/10.1016\/j.ajog.2016.06.023.","DOI":"10.1016\/j.ajog.2016.06.023"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_038","doi-asserted-by":"crossref","unstructured":"Roberts, D, Brown, J, Medley, N, Dalziel, SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017;3:CD004454. https:\/\/doi.org\/10.1002\/14651858.CD004454.pub3.","DOI":"10.1002\/14651858.CD004454.pub3"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_039","doi-asserted-by":"crossref","unstructured":"Brownfoot, FC, Gagliardi, DI, Bain, E, Middleton, P, Crowther, CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2013:CD006764. https:\/\/doi.org\/10.1002\/14651858.CD006764.pub3.","DOI":"10.1002\/14651858.CD006764.pub3"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_040","doi-asserted-by":"crossref","unstructured":"Ballard, PL, Granberg, P, Ballard, RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 1975;56:1548\u201354. https:\/\/doi.org\/10.1172\/jci108236.","DOI":"10.1172\/JCI108236"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_041","doi-asserted-by":"crossref","unstructured":"Ballard, P. Hormones and lung maturation. Monogr Endocrinol 1986;28:1.","DOI":"10.1007\/978-3-642-82483-8_1"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_042","doi-asserted-by":"crossref","unstructured":"Ballard, PL, Ballard, RA. Glucocorticoid receptors and the role of glucocorticoids in fetal lung development. Proc Natl Acad Sci U S A. 1972;69:2668\u201372. https:\/\/doi.org\/10.1073\/pnas.69.9.2668.","DOI":"10.1073\/pnas.69.9.2668"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_043","doi-asserted-by":"crossref","unstructured":"Howie, R, Liggins, G. The New Zealand study of antepartum glucocorticoid treatment. In: Farrell, PM, editor. Lung development: biological and clinical perspectives. New York: Academic Press; 1983, Vol. 2:255 p.","DOI":"10.1016\/B978-0-12-249702-5.50023-6"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_044","doi-asserted-by":"crossref","unstructured":"Khandelwal, M, Chang, E, Hansen, C, Hunter, K, Milcarek, B. Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. Am J Obstet Gynecol. 2012;206:201.e1\u201311. https:\/\/doi.org\/10.1016\/j.ajog.2012.01.025.","DOI":"10.1016\/j.ajog.2012.01.025"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_045","unstructured":"Danesh, A, Janghorbani, M, Khalatbari, S. Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. J Res Med Sci 2012;17:911\u20137."},{"key":"2023040100043917217_j_jpm-2022-0066_ref_046","doi-asserted-by":"crossref","unstructured":"Crowther, CA, Haslam, RR, Hiller, JE, Doyle, LW, Robinson, JS, Australasian Collaborative Trial of Repeat Doses of Steroids Study G. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006;367:1913\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(06)68846-6.","DOI":"10.1016\/S0140-6736(06)68846-6"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_047","doi-asserted-by":"crossref","unstructured":"Crowther, CA, McKinlay, CJ, Middleton, P, Harding, JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2015:CD003935.https:\/\/doi.org\/10.1002\/14651858.CD003935.pub3.","DOI":"10.1002\/14651858.CD003935.pub4"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_048","doi-asserted-by":"crossref","unstructured":"Crowther, CA, Middleton, PF, Voysey, M, Askie, L, Zhang, S, Martlow, TK, et al.. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: an individual participant data meta-analysis. PLoS Med 2019;16:e1002771. https:\/\/doi.org\/10.1371\/journal.pmed.1002771.","DOI":"10.1371\/journal.pmed.1002771"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_049","doi-asserted-by":"crossref","unstructured":"Wapner, RJ, Sorokin, Y, Thom, EA, Johnson, F, Dudley, DJ, Spong, CY, et al.. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006;195:633\u201342. https:\/\/doi.org\/10.1016\/j.ajog.2006.03.087.","DOI":"10.1016\/j.ajog.2006.03.087"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_050","doi-asserted-by":"crossref","unstructured":"Sawady, J, Mercer, BM, Wapner, RJ, Zhao, Y, Sorokin, Y, Johnson, F, et al.. The National Institute of Child Health and Human development maternal-fetal medicine Units Network beneficial effects of antenatal repeated steroids study: impact of repeated doses of antenatal corticosteroids on placental growth and histologic findings. Am J Obstet Gynecol 2007;197:281.e1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2007.06.041.","DOI":"10.1016\/j.ajog.2007.06.041"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_051","doi-asserted-by":"crossref","unstructured":"Cartwright, RD, Crowther, CA, Anderson, PJ, Harding, JE, Doyle, LW, McKinlay, CJD. Association of fetal growth restriction with neurocognitive function after repeated antenatal betamethasone treatment vs placebo: secondary analysis of the ACTORDS randomized clinical trial. JAMA Netw Open 2019;2:e187636. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7636.","DOI":"10.1001\/jamanetworkopen.2018.7636"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_052","doi-asserted-by":"crossref","unstructured":"Saccone, G, Berghella, V. Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ 2016;355:i5044. https:\/\/doi.org\/10.1136\/bmj.i5044.","DOI":"10.1136\/bmj.i5044"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_053","doi-asserted-by":"crossref","unstructured":"Stutchfield, P, Whitaker, R, Russell, I, Antenatal Steroids for Term Elective Caesarean Section Research T. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ 2005;331:662. https:\/\/doi.org\/10.1136\/bmj.38547.416493.06.","DOI":"10.1136\/bmj.38547.416493.06"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_054","doi-asserted-by":"crossref","unstructured":"Sotiriadis, A, McGoldrick, E, Makrydimas, G, Papatheodorou, S, Ioannidis, JP, Stewart, F, et al.. Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes. Cochrane Database Syst Rev. 2021;12:CD006614. https:\/\/doi.org\/10.1002\/14651858.CD006614.pub4.","DOI":"10.1002\/14651858.CD006614.pub4"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_055","doi-asserted-by":"crossref","unstructured":"Palas, D, Ehlinger, V, Alberge, C, Truffert, P, Kayem, G, Goffinet, F, et al.. Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study. BJOG 2018;125:1164\u201370. https:\/\/doi.org\/10.1111\/1471-0528.15014.","DOI":"10.1111\/1471-0528.15014"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_056","doi-asserted-by":"crossref","unstructured":"Gyamfi, C, Mele, L, Wapner, RJ, Spong, CY, Peaceman, A, Sorokin, Y, et al.. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol 2010;203:219.e1\u20135. https:\/\/doi.org\/10.1016\/j.ajog.2010.04.047.","DOI":"10.1016\/j.ajog.2010.04.047"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_057","doi-asserted-by":"crossref","unstructured":"Della Torre, M, Hibbard JU, Jeong, H, Fischer, JH. Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. Am J Obstet Gynecol 2010;203:254.e1\u201312. https:\/\/doi.org\/10.1016\/j.ajog.2010.06.029.","DOI":"10.1016\/j.ajog.2010.06.029"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_058","doi-asserted-by":"crossref","unstructured":"Tsakiridis, I, Mamopoulos, A, Chalkia-Prapa, EM, Athanasiadis, A, Dagklis, T. Preterm premature rupture of membranes: a review of 3 National guidelines. Obstet Gynecol Surv 2018;73:368\u201375. https:\/\/doi.org\/10.1097\/ogx.0000000000000567.","DOI":"10.1097\/OGX.0000000000000567"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_059","doi-asserted-by":"crossref","unstructured":"Harding, JE, Pang, J, Knight, DB, Liggins, GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol. 2001;184:131\u20139. https:\/\/doi.org\/10.1067\/mob.2001.108331.","DOI":"10.1067\/mob.2001.108331"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_060","doi-asserted-by":"crossref","unstructured":"Brookfield, KF, El-Sayed, YY, Chao, L, Berger, V, Naqvi, M, Butwick, AJ. Antenatal corticosteroids for preterm premature rupture of membranes: single or repeat course? Am J Perinatol. 2015;32:537\u201344. https:\/\/doi.org\/10.1055\/s-0034-1396690.","DOI":"10.1055\/s-0034-1396690"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_061","doi-asserted-by":"crossref","unstructured":"Yang, SH, Choi, SJ, Roh, CR, Kim, JH. Multiple courses of antenatal corticosteroid therapy in patients with preterm premature rupture of membranes. J Perinat Med 2004;32:42\u20138. https:\/\/doi.org\/10.1515\/JPM.2004.007.","DOI":"10.1515\/JPM.2004.007"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_062","doi-asserted-by":"crossref","unstructured":"Torrance, HL, Derks, JB, Scherjon, SA, Wijnberger, LD, Visser, GH. Is antenatal steroid treatment effective in preterm IUGR fetuses? Acta Obstet Gynecol Scand 2009;88:1068\u201373. https:\/\/doi.org\/10.1080\/00016340903176784.","DOI":"10.1080\/00016340903176784"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_063","doi-asserted-by":"crossref","unstructured":"Blankenship, SA, Brown, KE, Simon, LE, Stout, MJ, Tuuli, MG. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020;2:100215. https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100215.","DOI":"10.1016\/j.ajogmf.2020.100215"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_064","doi-asserted-by":"crossref","unstructured":"Familiari, A, Prefumo, F, Napolitano, R, Visser, G, Wolf, H, Lees, C. VP38.03: antenatal corticosteroids and perinatal outcomes in late fetal growth restriction: analysis of a prospective cohort. Ultrasound Obstet Gynecol 2021;58:261. https:\/\/doi.org\/10.1002\/uog.24572.","DOI":"10.1002\/uog.24572"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_065","doi-asserted-by":"crossref","unstructured":"Amiya, RM, Mlunde, LB, Ota, E, Swa, T, Oladapo, OT, Mori, R. Antenatal corticosteroids for reducing adverse maternal and child outcomes in special populations of women at risk of imminent preterm birth: a systematic review and meta-analysis. PLoS One 2016;11:e0147604. https:\/\/doi.org\/10.1371\/journal.pone.0147604.","DOI":"10.1371\/journal.pone.0147604"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_066","doi-asserted-by":"crossref","unstructured":"Jolley, JA, Rajan, PV, Petersen, R, Fong, A, Wing, DA. Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes. Diabetes Res Clin Pract. 2016;118:98\u2013104. https:\/\/doi.org\/10.1016\/j.diabres.2016.06.005.","DOI":"10.1016\/j.diabres.2016.06.005"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_067","doi-asserted-by":"crossref","unstructured":"Langen, ES, Kuperstock, JL, Sung, JF, Taslimi, M, Byrne, J, El-Sayed, YY. Maternal glucose response to betamethasone administration. Am J Perinatol 2015;30:143\u20138. https:\/\/doi.org\/10.1055\/s-0034-1376387.","DOI":"10.1055\/s-0034-1376387"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_068","doi-asserted-by":"crossref","unstructured":"Jobe, AH. Quality improvement and antenatal steroids. J Pediatr 2021;232:9\u201310. https:\/\/doi.org\/10.1016\/j.jpeds.2020.12.073.","DOI":"10.1016\/j.jpeds.2020.12.073"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_069","doi-asserted-by":"crossref","unstructured":"Papageorgiou, AN, Desgranges, MF, Masson, M, Colle, E, Shatz, R, Gelfand, MM. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study. Pediatrics 1979;63:73\u20139. https:\/\/doi.org\/10.1542\/peds.63.1.73.","DOI":"10.1542\/peds.63.1.73"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_070","doi-asserted-by":"crossref","unstructured":"Braun, T, Sloboda, DM, Tutschek, B, Harder, T, Challis, JR, Dudenhausen, JW, et al.. Fetal and neonatal outcomes after term and preterm delivery following betamethasone administration. Int J Gynaecol Obstet 2015;130:64\u20139. https:\/\/doi.org\/10.1016\/j.ijgo.2015.01.013.","DOI":"10.1016\/j.ijgo.2015.01.013"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_071","doi-asserted-by":"crossref","unstructured":"Braun, T, Weichert, A, Gil, HC, Sloboda, DM, Tutschek, B, Harder, T, et al.. Fetal and neonatal outcomes after term and preterm delivery following betamethasone administration in twin pregnancies. Int J Gynaecol Obstet 2016;134:329\u201335. https:\/\/doi.org\/10.1016\/j.ijgo.2016.02.016.","DOI":"10.1016\/j.ijgo.2016.02.016"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_072","doi-asserted-by":"crossref","unstructured":"Wapner, RJ, Sorokin, Y, Mele, L, Johnson, F, Dudley, DJ, Spong, CY, et al.. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 2007;357:1190\u20138. https:\/\/doi.org\/10.1056\/nejmoa071453.","DOI":"10.1056\/NEJMoa071453"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_073","doi-asserted-by":"crossref","unstructured":"Asztalos, EV, Murphy, KE, Willan, AR, Matthews, SG, Ohlsson, A, Saigal, S, et al.. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013;167:1102\u201310. https:\/\/doi.org\/10.1001\/jamapediatrics.2013.2764.","DOI":"10.1001\/jamapediatrics.2013.2764"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_074","doi-asserted-by":"crossref","unstructured":"Raikkonen, K, Gissler, M, Kajantie, E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA 2020;323:1924\u201333. https:\/\/doi.org\/10.1001\/jama.2020.3937.","DOI":"10.1001\/jama.2020.3937"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_075","doi-asserted-by":"crossref","unstructured":"Sotiriadis, A, Tsiami, A, Papatheodorou, S, Baschat, AA, Sarafidis, K, Makrydimas, G. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol 2015;125:1385\u201396. https:\/\/doi.org\/10.1097\/aog.0000000000000748.","DOI":"10.1097\/AOG.0000000000000748"},{"key":"2023040100043917217_j_jpm-2022-0066_ref_076","doi-asserted-by":"crossref","unstructured":"Zephyrin, LC, Hong, KN, Wapner, RJ, Peaceman, AM, Sorokin, Y, Dudley, DJ, et al.. Gestational age-specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor. Am J Obstet Gynecol 2013;209:330.e1\u20137. https:\/\/doi.org\/10.1016\/j.ajog.2013.06.009.","DOI":"10.1016\/j.ajog.2013.06.009"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0066\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0066\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T09:51:28Z","timestamp":1680342688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0066\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":76,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,11]]},"published-print":{"date-parts":[[2022,5,25]]}},"alternative-id":["10.1515\/jpm-2022-0066"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2022-0066","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]}}}